Evaluating the Scientific Evidence
for Potential Reduced-Risk Tobacco Products



Core Committee Meeting
April 27-28, 2005
Bethesda, MD

  Attendees  
 
  Core Committee Members
    Alwynelle (Nell) Ahl, Highland Rim Consulting, TN
    Elizabeth L. Anderson, Sciences International, VA
    Nancy L. Buc, Buc & Beardsley, DC
    Carroll Cross, University of California at Davis, CA
    Louis D. Homer, Legacy Research, OR
    Joseph V. Rodricks, ENVIRON International, VA
    Emanuel Rubin, Thomas Jefferson University, PA
    Richard C. Schwing, Sustainable Visions, MI
    Richard Windsor, George Washington University, DC

Biological Effects Assessment Committee Representative
    Loren Koller, Environmental Health & Toxicology, OR

Exposure Committee Representative
    Robert Orth, Apis Discoveries, MO

Guest Speakers
    Norbert H. Kleinsasser, University of Regensburg, Germany
    Joellen Lewtas, University of Washington, Washington
    Joseph L. Mauderly, Lovelace Respiratory Research Institute, NM
    David C. White, University of Tennessee, TN
    Judith T. Zelikoff, New York University School of Medicine, NY

Registered Speakers
    Fawky Abdallah, Fawky Abdallah Company, NC
    Kroum Alexandrov, DKFZ/Biosynthec, Paris
    James W. Dillard, U.S. Smokeless Tobacco Company, CT
    Iman Emami, Biosynthec, Paris
    Anna-Lisa M. Fisher, British American Tobacco, UK
    David Johnson, Swedish Match North America, KY
    John H. Lauterbach, Lauterbach & Associates, GA
    Derek Mariner, British American Tobacco, UK
    Eian Massey, British American Tobacco, UK
    David O'Reilly, British American Tobacco, UK
    Christian Rolando, CNRS/Biosynthec, Paris

Other Registrants
    Bernard S. Appleton, Philip Morris USA, VA
    Scott Ballin, Alliance for Health, Economic and Agriculture Development, DC
    John E. Bunch, Conwood Company, TN
    John Carlisle, National Legal and Policy Center, MD
    Jeffrey T. Clark, Liggett Group, NC
    Elissa Dodge, Qorvis Communications, DC
    James Griffin, VA
    Christine Hall, Competitive Enterprise Institute, DC
    Milton Hejtmancik, Battelle, OH
    Kevin Jurin, KDJ Systems, MD
    Jonathan R. Kuhlman, Jacob Medinger & Finnegan LLP, NY
    Jacques Leclerc, Biosynthec, France
    Qiwei Liang, Philip Morris USA, VA
    George Lulham, JTI-MC, Canada
    Theresa Lupcho, Lauterbach & Associates, GA
    Elizabeth T. Marren, UST, Inc., CT
    Rosanne B. McTyre, The Weinberg Group, DC
    Paul E. Mendes, Philip Morris USA, VA
    Robert Reed, Boom Media Works, MD
    Hans J. Roethig, Philip Morris USA, VA
    Mohamadi A. Sarkar, Philip Morris USA, VA
    James E. Swauger, R.J. Reynolds Tobacco, NC
    Michael J. Taylor, Filtrona Technology Centre, UK
    Martin Unverdorben, Philip Morris USA, VA
    Donna Vallone, American Legacy Foundation, DC
    Maria Varga, Star Scientific, MD
    Ella Watson-Stryker, American Legacy Foundation, DC
    Chester J. Wrobleski, Jacob Medinger & Finnegan LLP, NY
    Lisa Zapawa, Pinney Associates, MD

LSRO Staff
    Amy Brownawell
    Daniel Byrd
    Michael Falk
    Kara Lewis
    Keith Lenghaus
    Shelia MacGregor
    Carmen Mones
    Paula Nixon
    Catherine St. Hilaire